Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral blood progenitor cells versus bone marrow

A K Fielding1, M J Watts, A H Goldstone

  • 1University College London Hospitals, England.

Journal of Hematotherapy
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Doctoral training to support sustainable soil geochemistry research in Africa.

Interface focus·2024
Same author

Charting achievements: a two-year retrospective of the society for environmental geochemistry and health (SEGH) and the evolving strategies.

Environmental geochemistry and health·2024
Same author

Assessing the spatial distribution of elemental concentrations in surface sediments of Lake Victoria, Kenya: implications for ecological health and management.

Environmental geochemistry and health·2024
Same author

Considerations for environmental biogeochemistry and food security for aquaculture around Lake Victoria, Kenya.

Environmental geochemistry and health·2023
Same author

Developments in Pb-210 methodologies to provide chronologies for environmental change.

Environmental geochemistry and health·2022
Same author

Editorial: The society for environmental geochemistry and health (SEGH): 50 years and beyond.

Environmental geochemistry and health·2022
Same journal

Comparative evaluation of procedures with a Baxter CS-3000 cell separator for collecting peripheral blood cells from children.

Journal of hematotherapy·1999
Same journal

Graft engineering of G-CSF-mobilized allogeneic leukapheresis products by counterflow centrifugal elutriation after CD34 column adsorption.

Journal of hematotherapy·1999
Same journal

Serum granulocyte colony-stimulating factor kinetics in children receiving intense chemotherapy with or without stem cell support.

Journal of hematotherapy·1999
Same journal

Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92.

Journal of hematotherapy·1999
Same journal

The differentiating effect of retinoic acid and vincristine on acute myeloid leukemia.

Journal of hematotherapy·1999
Same journal

Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapse.

Journal of hematotherapy·1999
See all related articles

Mobilized peripheral blood stem cell transplants shorten recovery time compared to bone marrow transplants. This review examines the comparative benefits of these hematopoietic stem cell sources.

Area of Science:

  • Hematology
  • Transplantation Medicine
  • Oncology

Background:

  • Hematopoietic stem cell transplantation is a critical treatment for various hematologic malignancies and other diseases.
  • Mobilized peripheral blood progenitor cells (PPCs) are increasingly used as an alternative to bone marrow (BM) grafts.
  • PPCs generally lead to faster engraftment and shorter aplasia periods post-transplantation.

Purpose of the Study:

  • To review and compare the relative merits of mobilized peripheral blood progenitor cells versus bone marrow grafts in transplantation.
  • To evaluate the impact of different stem cell sources on the duration of post-transplant aplasia.

Main Methods:

  • This is a review article, synthesizing existing literature and data.
  • The review focuses on comparing outcomes between peripheral blood progenitor cell transplantation and bone marrow transplantation.

Related Experiment Videos

  • Key outcome measures include the period of post-transplant aplasia and overall graft efficacy.

    • Main Results:

    • Transplantation using mobilized peripheral blood progenitor cells has generally resulted in a shorter period of post-transplant aplasia compared to bone marrow grafts.
    • While clinical observations suggest benefits, large prospective randomized studies are lacking to definitively establish the relative merits.
    • The review explores the existing evidence regarding the comparative efficacy of these two stem cell sources.

    Conclusions:

    • Mobilized peripheral blood progenitor cells appear to offer an advantage in reducing the duration of aplasia post-transplantation.
    • Further large-scale prospective randomized trials are needed to conclusively determine the superiority of either stem cell source.
    • Understanding the comparative benefits is crucial for optimizing hematopoietic stem cell transplantation protocols.